For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza
The public at large is cautioned of fraudulent activities and false commitments using the name of Cadila.

News & Events

  • CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza Read More >>

Corporate Governance

This Draft Manual is prepared with an objective to define the core principles of the internal governing system at CPL – encompassing policies, processes and authorities, and to ensure its strict implementation in order to achieve effective management of the businesses and efficiency in operations. This draft is for discussions purposes only and upon consideration and adoption of these guidelines by the Board of Directors of the Company, this Corporate Governance Manual shall become operational effective April 1, 2015.

The Board of Directors of Cadila Pharmaceuticals Limited endeavours to promote and maintain the highest standards of Corporate Governance at CPL and seek compliance with the guidelines, provisions and/or directions of this Manual and such other guidelines framed, at all times, in letter and spirit..

Counterfeit Drugs: In case of any information on /or availability of counterfeit products... Read More © 2019 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals